ILMN - Illumina, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
http://www.illumina.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees7,700

Key Executives

NameTitlePayExercisedYear Born
Mr. Jay T. FlatleyExec. Chairman1.26MN/A1953
Mr. Francis A. deSouzaCEO, Pres & DirectorN/AN/A1971
Mr. Sam A. SamadCFO & Sr. VP896.83kN/A1970
Mr. Omead OstadanChief Product & Marketing OfficerN/AN/A1972
Ms. Aimee L. HoytChief People Officer & Sr. VP956.45kN/A1971
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array. It also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. has a collaboration with Roche to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. The company operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, China, and Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Corporate Governance

Illumina, Inc.’s ISS Governance QualityScore as of February 3, 2020 is 5. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 5; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.